Loading…
CSPC 2019 has ended
avatar for Grant Gibson

Grant Gibson

Triphase Accelerator
Chief Financial Officer

Grant Gibson joined Triphase in 2012 and has more than 20 years of experience focused on the biotech, pharma and life science industries, with expertise in corporate strategy, M&A, finance and operations. Throughout his career Grant has led several strategic and operational endeavours, including several biotech collaboration and licensing transactions, divestitures and acquisitions, post-acquisition integrations and new company start-ups.  Prior to joining Triphase, Grant was the CFO of Clearstone Central Laboratories – a private global central laboratory business spun-out from MDS Inc. Before joining Clearstone, Grant held senior finance positions with MDS Inc. – a public global CRO business, and Elan Pharmaceuticals – a global public pharmaceutical company focused on neurodegenerative and autoimmune diseases.  Prior to entering industry, Grant was a valuation expert for Deloitte & Touche in San Francisco, providing valuation consulting services to many leading global pharma/biotech and technology companies. Grant began his career with Ernst & Young and held various positions of increasing responsibility in the firm’s Corporate Finance and Audit & Assurance practice areas in both Canada and the United States. Grant obtained his Honors Business Administration (HBA) degree from the Richard Ivey School of Business at the University of Western Ontario and is a Chartered Professional Accountant (CPA) and Chartered Business Valuator (CBV).